1. Home
  2. HRMY vs EVCM Comparison

HRMY vs EVCM Comparison

Compare HRMY & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • EVCM
  • Stock Information
  • Founded
  • HRMY 2017
  • EVCM 2006
  • Country
  • HRMY United States
  • EVCM United States
  • Employees
  • HRMY N/A
  • EVCM N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • EVCM EDP Services
  • Sector
  • HRMY Health Care
  • EVCM Technology
  • Exchange
  • HRMY Nasdaq
  • EVCM Nasdaq
  • Market Cap
  • HRMY 2.0B
  • EVCM 1.7B
  • IPO Year
  • HRMY 2020
  • EVCM 2021
  • Fundamental
  • Price
  • HRMY $32.11
  • EVCM $10.67
  • Analyst Decision
  • HRMY Strong Buy
  • EVCM Buy
  • Analyst Count
  • HRMY 9
  • EVCM 12
  • Target Price
  • HRMY $54.22
  • EVCM $11.67
  • AVG Volume (30 Days)
  • HRMY 624.9K
  • EVCM 255.8K
  • Earning Date
  • HRMY 08-05-2025
  • EVCM 08-05-2025
  • Dividend Yield
  • HRMY N/A
  • EVCM N/A
  • EPS Growth
  • HRMY 13.13
  • EVCM N/A
  • EPS
  • HRMY 2.62
  • EVCM N/A
  • Revenue
  • HRMY $744,852,000.00
  • EVCM $703,186,000.00
  • Revenue This Year
  • HRMY $20.10
  • EVCM N/A
  • Revenue Next Year
  • HRMY $18.01
  • EVCM $6.31
  • P/E Ratio
  • HRMY $12.25
  • EVCM N/A
  • Revenue Growth
  • HRMY 20.62
  • EVCM 7.84
  • 52 Week Low
  • HRMY $26.47
  • EVCM $8.10
  • 52 Week High
  • HRMY $41.61
  • EVCM $12.35
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 42.69
  • EVCM 62.56
  • Support Level
  • HRMY $31.25
  • EVCM $9.47
  • Resistance Level
  • HRMY $33.69
  • EVCM $9.82
  • Average True Range (ATR)
  • HRMY 1.03
  • EVCM 0.29
  • MACD
  • HRMY -0.15
  • EVCM 0.10
  • Stochastic Oscillator
  • HRMY 20.90
  • EVCM 99.22

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.

Share on Social Networks: